Back to top
more

Better trading starts here.

Brokerage Reports

Research for LXRX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

1 item in cart

View Cart/Checkout

Lexicon Pharmaceuticals, Inc. [LXRX]

Reports for Purchase

Showing records 21 - 40 ( 393 total )

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 21

09/25/2020

Company Report

Pages: 2

The New Lexicon

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 22

08/13/2020

Industry Report

Pages: 18

PacGrow Healthcare Conference: Day 1 - 2 Recap

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 23

08/03/2020

Company Report

Pages: 10

Realignment Returns Company to its Roots; Sights on Pipeline - LX9211/DPNP

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 24

07/31/2020

Company Report

Pages: 2

Hitting the Reset Button - Hold

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 25

07/26/2020

Industry Report

Pages: 10

The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 26

07/22/2020

Company Report

Pages: 2

Four Who? Four What?

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 27

05/22/2020

Industry Report

Pages: 73

Acromegaly Market Update

Provider: H.C. Wainwright & Co., Inc.

Analyst: TSAO D

Price: 150.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 28

04/28/2020

Company Report

Pages: 2

Xermelo Tops Q1 Expectations - Hold

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 29

04/28/2020

Company Report

Pages: 8

Strong Q1 XERMELO? Sales; Shifting Focus to XERMELO?/BTC - LX9211

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 30

04/24/2020

Industry Report

Pages: 13

The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 31

03/23/2020

Company Report

Pages: 8

Early-Close of Outcomes Trials, Clarity Expected in Early May

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 32

03/23/2020

Company Report

Pages: 2

Cash, COVID-19 , Kill Sota Studies - Hold

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 33

03/16/2020

Daily Note

Pages: 13

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 34

03/15/2020

Company Report

Pages: 8

Q4/FY19; Ph3 T2D Data - Ph2 Progress for BTC - Neuropathic Pain in H1:20

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 35

03/13/2020

Company Report

Pages: 2

Q4 Results- Hold

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 36

01/31/2020

Industry Report

Pages: 16

The Monthly Check-Up

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 50.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 37

01/23/2020

Company Report

Pages: 8

ASCO Preview - Key 2020 Milestones

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 38

12/23/2019

Daily Note

Pages: 9

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 39

12/23/2019

Company Report

Pages: 2

SOTA-EMPA Has No Clothes

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Lexicon Pharmaceuticals, Inc.

Industry: Medical - Biomedical and Genetics

Record: 40

12/22/2019

Company Report

Pages: 8

Positive Topline Data from the Phase 3 SOTA-EMPA Trial

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party